NCT04416295

Selfcare MAnagement InteRvenTion in COPD (SMART COPD)

Completed NA Last updated 30 June 2021

What this trial tests

NA trial testing LifePod in Copd in 60 participants. Completed in 30 April 2021.

Timeline

1 August 2019

Primary endpoint
31 January 2021

30 April 2021

Quick facts

Lead sponsor	Lund University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	supportive care
Enrollment	60
Start date	1 August 2019
Primary completion	31 January 2021
Estimated completion	30 April 2021
Sites	1 location across Sweden

Drugs / interventions tested

• LifePod

Conditions studied

• Copd — all drugs for Copd →
• Assessment, Self — all drugs for Assessment, Self →
• Hospitalization — all drugs for Hospitalization →

Sponsor

Lund University

Who can join

Eligibility, any sex, with Copd or Assessment, Self. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate whether a digital support and communication platform for COPD patients after 6 months provides:

1. Decreased breathlessness on the basis of modified medical research council dyspnea scale \[mMRC\]
2. Improved health status and symptom relief based on COPD assessment scale \[CAT\]
3. Improved quality of life based on EQ-5D
4. Reduction in the number of incidents, hospital nights, the number of hospitalizations, outpatient contacts or the number of deaths related to COPD
5. A change in the classification of COPD severity based on GOLD A-D

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Integrated disease management interventions for patients with chronic obstructive pulmonary disease.
   Poot CC, Meijer E, Kruis AL, Smidt N, et al · · 2021 · cited 48× · PMID 34495549 · DOI 10.1002/14651858.cd009437.pub3